findmyKOL

Onyema Ogbuagu, MD

Enriched profile

Professor of Medicine (Infectious Diseases, AIDS) and of Pharmacology, Yale School of Medicine · Yale School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New Haven, CT · Northeast · United StatesSpecialtyInfectious DiseaseFocusHIV/AIDS Research and Interventions+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Onyema Ogbuagu is Professor of Medicine (Infectious Diseases, AIDS) and of Pharmacology, Yale School of Medicine at Yale School of Medicine. OpenAlex indexes 127 publications with 3,265 citations (h-index 21); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 15 Oct 2026

Overview

Updated 15 Oct 2026

Onyema Ogbuagu, MD, is Professor of Medicine (Infectious Diseases, AIDS) and of Pharmacology, Yale School of Medicine. The public record shows 127 publications with 3,265 citations (h-index 21), centered on HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 8 companies.

  • Most recent indexed publication: 2026 · Science translational medicine
  • Top research focus: HIV/AIDS Research and Interventions
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV3 trialsHIV Infections2 trialsTuberculosis1 trialViral Hepatitis (B/C)

Research focus

OpenAlex concept fingerprint
HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and TreatmentHIV, Drug Use, Sexual RiskHepatitis C virus research

Drugs & molecules

across trials, industry payments and publications
Veklurygeneric · RemdesivirClinical trials—Industry payments57Publications2Sunlencageneric · LenacapavirClinical trials—Industry payments9Publications6Descovygeneric · Emtricitabine / tenofovir alafenamideClinical trials—Industry payments16Publications—Moderna Covid-19 VaccineClinical trials—Industry payments16Publications—Biktarvygeneric · Bictegravir / emtricitabine / tenofovir alafenamideClinical trials—Industry payments4Publications—Dovatogeneric · Dolutegravir / lamivudineClinical trials—Industry payments3Publications—CabenuvaClinical trials—Industry payments1Publications—NirmatrelvirClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trials—Industry payments145ViiV Healthcare CompanyClinical trials—Industry payments66ModernaTX, Inc.Clinical trials—Industry payments16Janssen Research & Development, LLCClinical trials—Industry payments15Janssen Pharmaceuticals, IncClinical trials—Industry payments7Janssen Scientific Affairs, LLCClinical trials—Industry payments4Pfizer Inc.Clinical trials—Industry payments4ViiV HealthcareClinical trials2Industry payments—GlaxoSmithKline, LLC.Clinical trials—Industry payments1Yale UniversityClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
127publications

Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.

3,265citations

Total citations across indexed works.

21h-index

Hirsch index (OpenAlex). i10-index 42.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    57.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor57.7%
    Juluca100%
    Part D<11 patients
  • Cardiovascular

    42.3%
    Statin42.3%
    Atorvastatin Calcium100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Lydia Barakat15Jessica Tuan14Merceditas S Villanueva13Hadas Dvory‐Sobol11Maricar F. Malinis11Jared M. Baeten10Moti N. Ramgopal10Nicolas Margot9Peter Jerome Ruane9Olayemi O. Osiyemi9Martin S. Rhee9Sorana Segal‐Maurer8Jean‐Michel Molina8Grace Igiraneza8Ritche Manos Hao7Jason M. Brunetta7Gordon E. Crofoot7Cynthia C Brinson7Karam Mounzer6Catherine M. Creticos6Mezgebe Berhe6Theo Hodge6Christoph C Carter6Moupali Das6Edwin DeJesus6Elijah Paintsil5Mukhtar Abdulmajid Adeiza5Michael Virata5Anthony Mills5Linda M. Gorgos5William E. Sanchez5David A. Wheeler4Benoît Trottier4Tanya Schreibman4Ian Wachekwa4Anchalee Avihingsanon4Gary Ian Sinclair4Cecilia Nuta4Olivier Manzi4Antonella Castagna4

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/onyema-ogbuagu-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    medicine.yale.edu/news-article/a-promising-injectable-for-hiv-prevention-yales-onyema-ogbuagu-explains-the-research

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MBBCh

    University of Calabar

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Fellow

    American College of Physicians (FACP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Fellow

    Infectious Diseases Society of America (FIDSA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Physicians

    2015
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Fellow

    Infectious Diseases Society of America

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Yale Antivirals and Vaccines Research Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Affiliated Faculty

    Yale Institute for Global Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Visiting Professor

    National University of Rwanda

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Program Director

    Liberia College of Physicians and Surgeons Internal Medicine Residency

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.